Previous Article | Next Article ![]()
J. Virol., Jan 1998, 65-72, Vol 72, No. 1
T Peng, M Ponce-de-Leon, H Jiang, G Dubin, JM Lubinski, RJ Eisenberg and GH Cohen
The herpes simplex virus type 1 (HSV-1) gH-gL complex which is found in the
virion envelope is essential for virus infectivity and is a major antigen
for the host immune system. However, little is known about the precise role
of gH-gL in virus entry, and attempts to demonstrate the immunologic or
vaccine efficacy of gH and gL separately or as the gH-gL complex have not
succeeded. We constructed a recombinant mammalian cell line (HL-7) which
secretes a soluble gH-gL complex, consisting of gH truncated at amino acid
792 (gHt) and full-length gL. Purified gHt-gL reacted with gH- and
gL-specific monoclonal antibodies, including LP11, which indicates that it
retains its proper antigenic structure. Soluble forms of gD (gDt) block HSV
infection by interacting with specific cellular receptors. Unlike soluble
gD, gHt-gL did not block HSV-1 entry into cells, nor did it enhance the
blocking capacity of gD. However, polyclonal antibodies to the complex did
block entry even when added after virus attachment. In addition, these
antibodies exhibited high titers of complement-independent neutralizing
activity against HSV-1. These sera also cross-neutralized HSV-2, albeit at
low titers, and cross-reacted with gH-2 present in extracts of
HSV-2-infected cells. To test the potential for gHt-gL to function as a
vaccine, BALB/c mice were immunized with the complex. As controls, other
mice were immunized with gD purified from HSV-infected cells or were sham
immunized. Sera from the gD- or gHt-gL-immunized mice exhibited high titers
of virus neutralizing activity. Using a zosteriform model of infection, we
challenged mice with HSV-1. All animals showed some evidence of infection
at the site of virus challenge. Mice immunized with either gD or gHt-gL
showed reduced primary lesions and exhibited no secondary zosteriform
lesions. The sham-immunized control animals exhibited extensive secondary
lesions. Furthermore, mice immunized with either gD or gHt-gL survived
virus challenge, while many control animals died. These results suggest
that gHt-gL is biologically active and may be a candidate for use as a
subunit vaccine.
Copyright © 1998, American Society for Microbiology
The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge
School of Dental Medicine, and Center for Oral Health Research, University of Pennsylvania, Philadelphia 19104, USA. tpeng@biochem.dental.upenn.edu
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»